• Home
  • About Us
    • Mission
    • History
    • Scientific Advisory Council
    • Advisory Management Committee
    • Specialist Advisors to the Executive Director
    • Member Companies
    • Participating Regulatory Authorities
    • Participating HTA and Coverage Bodies
  • Past Workshops
    • 2013-2012
    • 2011-2010
    • 2009-2008
    • 2007-2005
    • 2004-2002
  • CIRS Activities
    • Activities Schedule
    • Regulatory Programme
      • Benchmarking
      • Scorecards
    • Emerging Markets Programme
      • Emerging Markets Programme Research
    • HTA Programme
      • Research
  • Publications
    • Books
    • Journal Articles
    • Posters
    • Press Releases
    • R&D Briefings
    • White Papers
    • Workshop Synopses
  • UMBRA Initiative
    • Background
    • Methodologies
    • Regional Initiatives
    • Resources
    • UMBRA Update Newsletter
  • Member Login
  • Contact Us
  • Home
  • About Us
    • Mission
    • History
    • Scientific Advisory Council
    • Advisory Management Committee
    • Specialist Advisors to the Executive Director
    • Member Companies
    • Participating Regulatory Authorities
    • Participating HTA and Coverage Bodies
  • Past Workshops
    • 2013-2012
    • 2011-2010
    • 2009-2008
    • 2007-2005
    • 2004-2002
  • CIRS Activities
    • Activities Schedule
    • Regulatory Programme
      • Benchmarking
      • Scorecards
    • Emerging Markets Programme
      • Emerging Markets Programme Research
    • HTA Programme
      • Research
  • Publications
    • Books
    • Journal Articles
    • Posters
    • Press Releases
    • R&D Briefings
    • White Papers
    • Workshop Synopses
  • UMBRA Initiative
    • Background
    • Methodologies
    • Regional Initiatives
    • Resources
    • UMBRA Update Newsletter
  • Member Login
  • Contact Us
Home

Workshop Synopses

Workshop Synopsis, June 2011; Washington DC, USA: Visualising benefit-risk of the assessment of medicines: The key to developing a framework that informs stakeholder perspective and clarity of decision making

Workshop Synopsis, March 2011; Geneva, Switzerland: Evidentiary requirements in clinical development: synchronising phase III requirements to meet multiple needs

Workshop Synopsis, January 2011; Tokyo, Japan: Regional Alignment in Asia Pacific: What needs to be in the regulatory science “toolkit” to enable good regulatory decision making

Workshop Synopsis, October 2010; Surrey, UK: New development paradigms: building regulatory confidence for the early release of medicines

Workshop Synopsis, March 2009; Surrey, UK: Expediting patients’ access to medicines: Solutions to simultaneous submissions and approvals

© 2013 CIRS (Centre for Innovation in Regulatory Science)